Form 4: Revolution Medicines Executive Sells Shares
Insider Transaction (Form 4)
Jeff Cislini, SVP & General Counsel of Revolution Medicines, Inc., sold 765 shares of common stock on September 25, 2026 for $207.32 per share.
Summary
- Open-market sale: disposed of 765 Common Stock at $207.32 ($158,600) on September 25, 2026; holds 51,776 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $158,600 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jeff Cislini — Officer (SVP & General Counsel)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-25 | Open-market sale | Common Stock | 765 | $207 | $158.6K | 51,776 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-25 | Open-market sale (765 shares) |
Keywords
insider transaction, Form 4, RVMD, Revolution Medicines, Inc., bearish, Jeff Cislini
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.